A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases

Clinical trial NCT02941744 · COMPLETED

Trial details

NCT number: NCT02941744
Sponsor: Universitair Ziekenhuis Brussel
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IIIC Skin Melanoma Stage IV Skin Melanoma

Start date: 2016-03-01
Primary completion: 2018-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.